Zhili Xu

Nanoparticle-Based Drug Delivery Nanoplatforms for cancer theranostics Intraperitoneal and Appendiceal Malignancies Occupational and environmental lung diseases Pain Mechanisms and Treatments

Publications

Citations

639

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 2015

Research summary

AI-generated

Zhili Xu works at the intersection of materials science and biomedicine, developing nanoscale and micromotor-based systems for cancer treatment, drug delivery, and tissue repair. The research includes engineered nanoparticles, hydrogels, and micro/nanorobots designed to remodel tumor environments and enhance therapies such as chemotherapy, immunotherapy, and photodynamic therapy. Some recent work also addresses clinical topics such as surgical and anesthesia outcomes.

Nanoparticle-based drug deliveryMicro/nanorobots for cancer therapyTumor microenvironment remodelingHydrogels for tissue repair and treatmentClinical oncology and surgical outcomes

Publication activity has been generally steady with a notable increase in the most recent years, averaging about 5.4 papers per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence

Publications per year over the last 10 years — averaging 5.4/year recently

Recent publications

Publishes in

Figshare×8
International Journal of Nanomedicine×2
Advanced Functional Materials×2
Pharmacological Research×2
Frontiers in Medicine×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile